RBC Capital Maintains Outperform on Xylem, Raises Price Target to $145
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Deane Dray has maintained an Outperform rating on Xylem (NYSE:XYL) and increased the price target from $140 to $145, indicating a positive outlook on the company's stock.
February 07, 2024 | 5:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Deane Dray has reaffirmed an Outperform rating on Xylem and raised the price target from $140 to $145.
The increase in price target by RBC Capital reflects a positive outlook on Xylem's stock, suggesting confidence in the company's future performance. This analyst endorsement is likely to influence investor sentiment positively in the short term, potentially leading to an increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100